Zep, 70% recall — Zep Inc (Class II)

Zep Inc is recorded by the U.S. Food and Drug Administration (FDA) as recalling Zep, 70% — a Class II recall, initiated 2026-05-22 and posted to the FDA enforcement report on 2026-06-17, under recall number D-0586-2026. Status Ongoing, with no termination date on the record. The reason the FDA record carries is, verbatim: “Microbial contamination of sterile products”. From the product description, the form is spray and the strengths given are 70%, 55 G and 208 L. 1 National Drug Code number is printed in the record: 66949-133-85. Distribution is recorded as “US Nationwide” — Nationwide (US), with the recalling firm on record in GA, United States. It is the only recall number the FDA has filed under event ID 99112. 26 days separate the firm's initiation date from the FDA's report date on this record. Values are reproduced from the linked openFDA report; regulatory information, not medical advice.

Regulatory snapshot

Recall number D-0586-2026
FDA event ID 99112
Classification Class II (intermediate regulatory tier)
Status Ongoing
Recalling firm Zep Inc
Recall initiated 2026-05-22
Reported by FDA 2026-06-17
Report lag 26 days from initiation to report
Distribution US Nationwide. — Nationwide (US)
Firm location on record GA, United States
Product description (source) Zep, Alcohol Sanitizer Spray, Ethanol 70%, Net Contents 55 Gallons 208 Liters, Made in USA, A Zep Inc. Brand, Distributed by: Zap Inc., 350 Joe Frank Harris Parkway, SE, Emerson, GA 30137, NDC 66949-133-85.

Reason reported by FDA

Microbial contamination of sterile products

5 words from the enforcement report field reason_for_recall, reproduced without edit — the firm's own wording, not an assessment.

Product identifiers in this record

7 identifying values matched by exact pattern in the 34-word product description above; each is a literal substring of it.

Product named Zep
Form Spray
Strength 70% · 55 G · 208 L
NDC 66949-133-85
Stated origin USA
Distributed by Zap Inc., 350 Joe Frank Harris Parkway

Reported in the same month (2026-06)

74 enforcement reports carry a report date in 2026-06; these 8 are the Class II ones nearest this record.

Recall recordRecall numberRecalling firmFDA tierReported
Duloxetine Delayed-Release Capsules, 30mgD-0582-2026Breckenridge Pharmaceutical, Inc.Class II2026-06-17
Duloxetine Delayed-Release Capsules, 60mgD-0583-2026Breckenridge Pharmaceutical, Inc.Class II2026-06-17
GSMS Incorporated, 1,000 MGD-0587-2026Golden State Medical Supply Inc.Class II2026-06-17
Minocycline Hydrochloride Extended-Release Tablets, 115 mgD-0597-2026Ascend Laboratories, LLCClass II2026-06-17
Budesonide Inhalation Suspension, 1mg/2mLD-0607-2026Sun Pharmaceutical Industries IncClass II2026-06-17
Lidocaine HCl Injection USPD-0554-2026Spectra Medical Devices, LLCClass II2026-06-10
Duloxetine DR Capsules, 30 mgD-0555-2026Asclemed Usa Inc.Class II2026-06-10
Amlodipine and Olmesartan Medoxomil Tablets, 5mg/40mgD-0556-2026Ascend Laboratories, LLCClass II2026-06-10

Nearest Class II recalls by date

213 of 250 indexed records share the Class II tier; the 8 nearest to 2026-06-17 by report date are listed here.

Recall recordRecall numberRecalling firmStrength / formReported
KIRKLAND Signature, 1000 mgD-0557-2026Guardian Drug Co. Inc.1000 mg2026-06-10
HALEON CALCIUM CARBONATE TUMS ANTACID, 1000 mgD-0558-2026Guardian Drug Co. Inc.1000 mg · Tablets2026-06-10
HALEON CALCIUM CARBONATE TUMS ANTACID, 750 mgD-0559-2026Guardian Drug Co. Inc.750 mg · Tablets2026-06-10
Good Neighbor Pharmacy, 750 mgD-0560-2026Guardian Drug Co. Inc.750 mg2026-06-10
Good Neighbor Pharmacy, 1000 mgD-0561-2026Guardian Drug Co. Inc.1000 mg · Chewable Tablets2026-06-10
Extra strength Antacid Calcium Carbonate 750 mgD-0562-2026Guardian Drug Co. Inc.750 mg · Chewable Tablets2026-06-10
24/7 life BY 7-ELEVEND-0563-2026Guardian Drug Co. Inc.7 l · Chewable Tablets2026-06-10
MARKET BASKET ANTACID Calcium Carbonate 1000 mgD-0564-2026Guardian Drug Co. Inc.1000 mg · Tablets2026-06-10

Reading this record

Class II is the FDA's own severity tier for the recall action — 213 of the 250 indexed records carry it — and it describes the agency's assessment of the action, not a risk statement about any individual. Match a package against 66949-133-85 at the FDA source to confirm it is covered.

Namespace context: the Class II index (213 records) and the recall hub (250 records, 118 FDA events); Zep Inc (1 indexed records) aggregates this firm across datasets.

Coverage and limits of this record

This page reflects the openFDA enforcement report for D-0586-2026 as ingested on 2026-08-22, which can lag the live FDA record and omits detail held only in primary documents. It offers no clinical assessment, no advice about whether to use any product, and no substitute. For any health question consult a qualified healthcare professional.

Source & provenance

Official source
https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0586-2026%22
Source dataset
openFDA Drug Enforcement API
Publication date
2026-06-17
Ingested
2026-08-22
Record hash
5e754c00c3a91027

Verify every value against the official FDA source above. This site links to the regulator's record rather than replacing it.